LD-2 disclosure · 1st Quarter - Report
AMYLIN PHARMACEUTICALS
Client
- Location
- District of Columbia · United States of America
Registrant
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
4 issuesHealth Issues
Prevention, diagnosis and treatment of diabetes Diabetes issues related to implementation of provisions of Pub. L. 111-148 (Patient Protection and Affordable Care Act of 2010)
Lobbyistsmr WILLIAM A FRANCO · CRAIG BURTON
TargetedSENATE · HOUSE OF REPRESENTATIVES
Copyright/Patent/Trademark
Exclusivity, damages, estoppel, post grant review and inter partes review provisions in the America Invents Act (S. 23, H.R. 1249)
Lobbyistsmr WILLIAM A FRANCO · CRAIG BURTON
TargetedSENATE · HOUSE OF REPRESENTATIVES
Pharmacy
Perscription Drug User Fee Act reauthorization FDA funding and agency effectiveness Drug importation issues
Lobbyistsmr WILLIAM A FRANCO · CRAIG BURTON
TargetedSENATE · HOUSE OF REPRESENTATIVES
Budget/Appropriations